We are live on
!
Find out more
NI
Nuance Investments Portfolio holdings
AUM
$588M
1-Year Est. Return
6.93%
This Fund
S&P 500
This Quarter
Est. Return
+0.87%
1 Year Est. Return
+6.93%
3 Year Est. Return
-3.13%
5 Year Est. Return
-5.61%
10 Year Est. Return
+43.7%
AUM
$4.72B
AUM Growth
-$53.9M
(-1.1%)
Cap. Flow
-$93.9M
Cap. Flow
% of AUM
-1.99%
Top 10 Holdings %
Top 10 Hldgs %
58.23%
Holding
58
New
2
Increased
25
Reduced
24
Closed
7
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Zimmer Biomet
ZBH
|
+$130M |
| 2 |
Globus Medical
GMED
|
+$118M |
| 3 |
3M
MMM
|
+$99.7M |
| 4 |
Kimberly-Clark
KMB
|
+$65M |
| 5 |
SCHW
Charles Schwab
SCHW
|
+$47M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Baxter International
BAX
|
+$252M |
| 2 |
Clorox
CLX
|
+$73.9M |
| 3 |
ICU Medical
ICUI
|
+$73.3M |
| 4 |
Everest Group
EG
|
+$64.2M |
| 5 |
Dentsply Sirona
XRAY
|
+$61.7M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 30.79% |
| 2 | Financials | 19.44% |
| 3 | Consumer Staples | 15.91% |
| 4 | Industrials | 14.81% |
| 5 | Real Estate | 7.62% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
51
Unilever
UL
$136B
| $567K | 0.01% |
9,708
-2,909
| -23% | -$165K |
|
|
52
Baxter International
BAX
$14.2B
| – | – |
-4,946,583
| Closed | -$252M |
|
53
Brown-Forman Class B
BF.B
$13.1B
| – | – |
-183,662
| Closed | -$12.1M |
|
54
iShares S&P Mid-Cap 400 Value ETF
IJJ
$8.97B
| – | – |
-11,980
| Closed | -$1.21M |
|
55
MetLife
MET
$62.1B
| – | – |
-4,022
| Closed | -$291K |
|
56
UMB Financial
UMBF
$11.1B
| – | – |
-171,685
| Closed | -$14.3M |
|
57
Valley National Bancorp
VLY
$8.04B
| – | – |
-2,419,015
| Closed | -$27.4M |
|
58
Essential Utilities
WTRG
$11.4B
| – | – |
-281,329
| Closed | -$13.4M |
|
Similar funds
DP
MC
PFG
FMI
EGWAG
GIM
FL
TAM
Nuance Investments's Q1 2023 Portfolio in Review
As of Q1 2023, Nuance Investments held 58 positions worth $4.72B, down 1.1% from $4.77B the previous quarter. Its ten largest holdings account for 58% of the portfolio.
Nuance Investments's Q1 2023 filing shows 2 new, 25 increased, 24 reduced and 7 closed positions. Its largest new stake was Cullen/Frost Bankers: 104,288 shares worth $11M. The largest sale was Baxter International, an estimated $252M.
By sector, the portfolio is most concentrated in Healthcare at 31% of assets, down from 31% a quarter earlier, followed by Financials and Consumer Staples.
- Nuance Investments's largest Q1 2023 buy was Cullen/Frost Bankers: 104,288 shares worth $11M.
- Nuance Investments added most to Zimmer Biomet in Q1 2023, an estimated $130M increase.
- Nuance Investments's biggest Q1 2023 reduction was Clorox, cutting an estimated $73.9M.
- Nuance Investments fully exited Baxter International in Q1 2023, selling an estimated $252M.
- Nuance Investments's ten largest holdings make up 58% of its $4.72B portfolio in Q1 2023.
- Nuance Investments opened 2 new positions and closed 7 in Q1 2023.
- Nuance Investments's portfolio value fell 1.1% quarter-over-quarter to $4.72B.
Based on Nuance Investments's 13F filing for Q1 2023, filed 9 May 2023.